Ripple Therapeutics | Finanzwire

Basculer en Français

10456	Companies
219634	Keywords
149011	Articles
116135	Press releases

Home
Companies
Ripple Therapeutics

BRIEF

published on 10/15/2024 at 14:50, 1 year 7 months ago

Ripple Therapeutics Enters Agreements with Glaukos for Sustained Delivery Implants

Drug Delivery Licensing Agreements Ripple Therapeutics Glaukos Corporation Ophthalmic Therapeutics
PRESS RELEASE

published on 10/15/2024 at 14:45, 1 year 7 months ago

Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos
Ripple Therapeutics partners with Glaukos Corporation to develop sustained release implants for ophthalmic therapies, utilizing innovative drug delivery technology

Drug Delivery Technology Ripple Therapeutics Glaukos Corporation Ophthalmic Therapeutics Sustained Release Implants
BRIEF

published on 09/17/2024 at 14:35, 1 year 8 months ago

Ripple Therapeutics Announces Collaboration with AbbVie for Glaucoma Therapy Development

Partnership Drug Delivery Ophthalmology Glaucoma Therapy Biodegradable Implants
PRESS RELEASE

published on 09/17/2024 at 14:30, 1 year 8 months ago

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
AbbVie and Ripple collaborate to develop sustainable drug delivery implants for glaucoma treatment leveraging expertise and innovative technology

Glaucoma Drug Delivery AbbVie Ripple Implants

Accesswire

Published on 05/26/2026 at 20:00, 1 hour 13 minutes ago

RUM Reports Quarterly Financial Results for March 31, 2026
Published on 05/26/2026 at 17:40, 3 hours 33 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $25 Million Offering of Common Shares
Published on 05/26/2026 at 14:30, 6 hours 43 minutes ago

Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Published on 05/26/2026 at 14:30, 6 hours 43 minutes ago

Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Published on 05/26/2026 at 14:30, 6 hours 43 minutes ago

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides

View all ACCESSWIRE

EQS Group

Published on 05/26/2026 at 18:50, 2 hours 23 minutes ago

The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 2 hours 43 minutes ago

H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:30, 3 hours 43 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 16:30, 4 hours 42 minutes ago

M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Published on 05/26/2026 at 16:15, 4 hours 58 minutes ago

R. STAHL AG Management Board member Dr. Claus Bischoff resigns from his office as Management Board member at his own request and for personal reasons and will leave by mutual agreement as of 31 May 20

Les Echos

Published on 05/26/2026 at 18:39, 2 hours 33 minutes ago

Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 3 hours 28 minutes ago

EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 15:00, 6 hours 13 minutes ago

Resolutions Ordinary and Extraordinary General Meetings
Published on 05/26/2026 at 07:59, 13 hours 14 minutes ago

Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Published on 05/25/2026 at 17:45, 1 day 3 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE